99mTc-MIBI scan in mammary pagets disease: A case report

Journal of Korean Medical Science

Volumn 14, Issue 6, 1999, Pages 675-678

  Han, Sehwan ^a   Kim, Jung Sook ^a   Kim, Bang Soon ^a   Koh, Il Hyang ^a   Park, Kyeongmee ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Breast; Diagnosis; Paget's disease, mammary; Technetium Tc 99m sestamibi

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BREAST TUMOR; CASE REPORT; FEMALE; HUMAN; MIDDLE AGED; NIPPLE; PAGET NIPPLE DISEASE; PATHOLOGY; SCINTISCANNING; SKIN;

BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NIPPLES; PAGET'S DISEASE, MAMMARY; SKIN; TECHNETIUM TC 99M SESTAMIBI;

EID: 0033251417     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.6.675     Document Type: Article

References (20)

1. Scopinaro F, Schillaci O, Scarpini M, Mingazzini PL, DiMacio L, Banci M, Danieli R, Zerilli M, Limiti MR, Colella AC. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994; 21: 984-7.
2. Uriarte I, Carril JM, Quirce R, Gutierrez-Mendiguchia C, Blanco I, Banzo I, Vega A, Hernandez A. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 1998; 25: 491-6.
3. Wilson CBJH. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and non-invasive dynamic method. Cancer Res 1992: 1592-7.
4. Fujii H, Nakamura K, Kubo A, Enomoto K, Ikeda T, Kubota T, Matsuzaki SW, Kitajima M. 99mTc-MIBI scintigraphy as an indicator of the chemosensitivity of anthracyclines in patients with breast cancer. Anticancer Res 1998; 18: 4601-5.
5. Palmedo H, Biersack HJ, Lastoria S, Maublant J, Prats E, Stegner HE, Bourgeois P, Hustinx R, Hilson AJW, Bischof-Delaloye A. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 1998; 25: 375-85.
6. Scorpinaro F, Mezi S, Lerardi M, De Vincentis G, Tiberio NS, David V, Maggi S, Sallusti E, Modesti M. 99mTc MIBI prone Scintimammography in patients with suspicious breast cancer: relationship with mammography and tumor size. Int J Oncol 1998; 12: 661-4.
7. Fujii H, Nakamura K, Kubo A, Enomoto K, Ikeda T, Kubota T, Matsuzaki SW, Kitajima M. Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99mTc-MIBI scintimammography. Ann Nucl Med 1998; 12: 307-12.
8. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D. Subcellular distribution analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-21.
9. Delmon-Moingeon LI, Piwnica-Worms D, Abbeele ADV, Holman BL, Davison A, Jones AG. Uptake of the cation (2-methoxyisobutylisonitrile)-Technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-202.
10. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-Methoxyisobutyl Isonitrile) Technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-38.
11. Davis S, Weiss MJ, Wong JR, Lampidis TJ, Chen LB. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem 1985; 260: 13844-50.
12. Kiefer H, Blume AJ, Kaback HR. Membrane potential changes during mitogenic stimulation of mouse spleen lymphocytes. Proc Natl Acad Sci USA 1980; 77: 2200-4.
13. Crane P, Laliberte R, Hemingway S, Thoolen M, Orlndi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993; 20: 20-5.
14. Piwnica-Worms D, Chiu ML, Kronauge JF. Detection of Adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI. Cancer Chemother Pharmacol 1993; 32: 385-91.
15. Piwnica-Worms D, Kronauge JF, Chiu ML. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells. J Nucl Med 1991; 32: 1992-9.
16. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 1990; 31: 464-72.
17. Okada RD, Glover D, Gaffney T, Willimas S. Myocardial kinetics of technetium-99m hexakis 2-methoxy-2methylpropylisonitrile. Circulation 1988; 77: 491-8.
18. Yim JH, Wick MR, Philpott GW, Norton JA, Doherty GM. Underlying pathology in mammary Paget's disease. Ann Surg Oncol 1997; 4: 287-92.
19. Kollmorgen DR, Varanasi JS, Edge SB, Carson WE III. Paget's disease of the breast: a 33-year experience. J Am Coll Surg 1998; 187: 171-7.
20. Mezi S, Scopinaro F, Marzullo A, Sallusti E, David V, Lerardi M, Tiberio NS, Modesti M. 99m Tc MIBI prone scintimammography in breast Paget's disease: a case report. Oncol Rep 1999; 6: 45-8.